Biopolymers · 2014 · 26 citations · 37 references
Life SciencesBiochemistryMolecular BiologyCell SignalingProtein BiochemistryStructural BiologyLigand BindingPeptide ChemistryPeptide Drug DiscoveryProtein BindingProtein PhosphorylationProtein StructureAntimitotic ActivityAntimitotic TreatmentsCationic PeptidesPeptide Structure - Activity RelationshipsPolo-like Kinase FunctionPolo-like Kinase InhibitionPolo-like Kinase InhibitorsProper Function
Binding of polo-like kinase 1 (Plk1) polo-box domains (PBDs) to phosphothreonine (pThr)/phosphoserine (pSer)-containing sequences is critical for the proper function of Plk1. Although high-affinity synthetic pThr-containing peptides provide starting points for developing PBD-directed inhibitors, to date the efficacy of such peptides in whole cell assays has been poor. This potentially reflects limited cell membrane permeability arising, in part, from the di-anionic nature of the phosphoryl group or its mimetics. In our current article we report the unanticipated on-resin N(τ)-alkylation of histidine residues already bearing a N(π)- alkyl group. This resulted in cationic imidazolium-containing pThr peptides, several of which exhibit single-digit nanomolar PBD-binding affinities in extracellular assays and improved antimitotic efficacies in intact cells. We enhanced the cellular efficacies of these peptides further by applying bio-reversible pivaloyloxymethyl (POM) phosphoryl protection. New structural insights presented in our current study, including the potential utility of intramolecular charge masking, may be useful for the further development of PBD-binding peptides and peptide mimetics.
37
W. Minor, M. Cymborowski, Zbyszek Otwinowski et al. · Acta Crystallographica Section D Biological Crystallography · 2006 · 2.2K citations · Full text